Filtered By:
Vaccination: Vaccines
Countries: Japan Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 3080 results found since Jan 2013.
Evaluation the effect of dietary vitamin E, sesamin and thymoquinone bioactive compounds on immunological response, intestinal traits and MUC-2 gene expression in broiler Japanese quails ( < em > Coturnix japonica < /em > )
Anim Biotechnol. 2023 Sep 20:1-11. doi: 10.1080/10495398.2023.2259437. Online ahead of print.ABSTRACTThe current study was performed to determine the effect of dietary vitamin E, sesamin and thymoquinone bioactive lignans derived from sesame and black seed on immunological response, intestinal traits and Mucin2 gene expression in broiler quails. Three hundred and fifty (one days-old) quails were allotted to seven dietary treatments with five replicates as an experimental randomized design study. Treatments were basal diet as a control, control +100 and +200 mg of vitamin E, sesamin and thymoquinone per each kg of diet resp...
Source: Animal Biotechnology - September 20, 2023 Category: Biotechnology Authors: Yaser Rahimian Farshid Kheiri Mostafa Faghani Source Type: research
Corrigendum to "Genotype prevalence and age distribution of human papillomavirus from infection to cervical cancer in Japanese women: A systematic review and meta-analysis" Vaccine 40(41) (2022) 5971-5996
Vaccine. 2023 Sep 1:S0264-410X(23)00787-9. doi: 10.1016/j.vaccine.2023.06.084. Online ahead of print.NO ABSTRACTPMID:37659892 | DOI:10.1016/j.vaccine.2023.06.084
Source: Cancer Control - September 2, 2023 Category: Cancer & Oncology Authors: Matthew Palmer Kota Katanoda Eiko Saito Cecilia Acuti Martellucci Shiori Tanaka Sayaka Ikeda Haruka Sakamoto Dorothy Machalek Julia M L Brotherton Jane S Hocking Source Type: research
Mumps vaccine hesitancy: Current evidence and an evidence-based campaign in Japan
CONCLUSION: Our study showed several sociodemographic factors significantly associated with mumps vaccination. Further research is needed to examine the relevance of our findings to the uptake of other voluntary vaccines among children.PMID:37640569 | DOI:10.1016/j.vaccine.2023.08.045
Source: Vaccine - August 28, 2023 Category: Allergy & Immunology Authors: Satoko Ugai Tomotaka Ugai Tetsuya Kanayama Hajime Kamiya Akihiko Saitoh Natalie Slopen Source Type: research
Impact of frequency and duration of freeze-dried inactivated tissue culture hepatitis A vaccine (Aimmugen ®) vaccination on antibody titers; a japanese cross-sectional study
CONCLUSIONS: Three doses of Aimmugen® are efficacious, but four or more doses induce more robust and sustained antibody production. Additionally, four or more doses may be effective when there is a need to ensure long-term immunity or risk of prolonged exposure.PMID:37620202 | DOI:10.1016/j.vaccine.2023.08.030
Source: Vaccine - August 24, 2023 Category: Allergy & Immunology Authors: Yohei Maki Naoki Edo Makoto Mizuguchi Mikihito Ikeda Masato Kitano Etsuko Kitagami Morichika Osa Shotaro Yamamoto Takunori Ogawa Takahiro Nakamura Akihiko Kawana Yoshifumi Kimizuka Source Type: research
Association Between Varicella-Zoster Virus Vaccination and Patient Experience in Elderly Japanese Outpatients: A Case-Control Study
CONCLUSIONS: PX was associated with past VZV vaccination. Physician recommendation for VZV vaccination was an intermediate factor between PX and VZV vaccination.PMID:37596883 | PMC:PMC10440083 | DOI:10.1177/21501319231192760
Source: Primary Care - August 19, 2023 Category: Primary Care Authors: Takashi Inaba Junji Haruta Ryohei Goto Tetsuhiro Maeno Source Type: research
Estimating the survival rate in glioblastoma multiforme patients who received a peptide vaccine: a systematic review and meta-analysis
CONCLUSION: Our study found that while peptide vaccination treatment did not increase second-year survival, it improved first-year survival. More research needs to be done to find effective vaccine-based treatments for GBM that can help patients survive longer.PMID:37587807 | DOI:10.2174/1389450124666230816114131
Source: Current Drug Targets - August 17, 2023 Category: Drugs & Pharmacology Authors: Masoumeh Eliyasi Dashtaki Zahra Moradi Yousef Moradi Elham Asadi Sorayya Ghasemi Source Type: research
DS-5670a, a novel mRNA-encapsulated lipid nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2: Results from a phase 2 clinical study
CONCLUSIONS: The novel mRNA-based vaccine candidate DS-5670a provided favorable immune responses against SARS-CoV-2 with a clinically acceptable safety profile. Confirmatory trials are currently ongoing to evaluate the safety and immunogenicity of DS-5670a as the primary vaccine and to assess the immunogenicity when administered as a heterologous or homologous booster.TRIAL REGISTRY: https://jrct.niph.go.jp/latest-detail/jRCT2071210086.PMID:37586958 | DOI:10.1016/j.vaccine.2023.07.012
Source: Vaccine - August 16, 2023 Category: Allergy & Immunology Authors: Kaoru Toyama Takashi Eto Kenji Takazawa Shinji Shimizu Tetsuo Nakayama Kei Furihata Yoshitaka Sogawa Masafumi Kumazaki Nao Jonai Satoko Matsunaga Fumihiko Takeshita Kazutaka Yoshihara Hitoshi Ishizuka Source Type: research
Modeling the impact of vaccination for the immunization Agenda 2030: Deaths averted due to vaccination against 14 pathogens in 194 countries from 2021 to 2030
Vaccine. 2023 Aug 1:S0264-410X(23)00854-X. doi: 10.1016/j.vaccine.2023.07.033. Online ahead of print.ABSTRACTBACKGROUND: The Immunization Agenda 2030 (IA2030) Impact Goal 1.1. aims to reduce the number of future deaths averted through immunization in the next decade. To estimate the potential impact of the aspirational coverage targets for IA2030, we developed an analytical framework and estimated the number of deaths averted due to an ambitious vaccination coverage scenario from 2021 to 2030 in 194 countries.METHOD: A demographic model was used to determine annual age-specific mortality estimates associated with vaccine c...
Source: Vaccine - August 3, 2023 Category: Allergy & Immunology Authors: Austin Carter William Msemburi So Yoon Sim Katy A M Gaythorpe Philipp Lambach Ann Lindstrand Raymond Hutubessy Source Type: research
A review of criteria strictness in "Toxicity Grading Scale for Healthy Adult and Adolescent Volunteers Enrolled in Preventive Vaccine Clinical Trials"
Vaccine. 2023 Jul 31:S0264-410X(23)00918-0. doi: 10.1016/j.vaccine.2023.07.072. Online ahead of print.ABSTRACTTo assess safety in vaccine development, stricter grading scales, such as the "Toxicity Grading Scale for Healthy Adult and Adolescent Volunteers Enrolled in Preventive Vaccine Clinical Trials" issued by the U.S. Food and Drug Administration (FDA grading scale), are required. However, concern exists that their strictness may lead to an overestimation of some adverse events (AEs). We analyzed the details of AEs in a phase I clinical trial of a preventive vaccine for infectious diseases. In this trial, we observed th...
Source: Vaccine - August 2, 2023 Category: Allergy & Immunology Authors: Motoki Amai Masanori Nojima Yoshikazu Yuki Hiroshi Kiyono Fumitaka Nagamura Source Type: research
